Market revenue in 2023 | USD 112.5 million |
Market revenue in 2030 | USD 114.4 million |
Growth rate | 0.2% (CAGR from 2023 to 2030) |
Largest segment | Conventional pcr |
Fastest growing segment | Conventional PCR |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Conventional PCR |
Key market players worldwide | Thermo Fisher Scientific Inc, Danaher Corp, Abbott Laboratories, Bio-Rad Laboratories Inc, Agilent Technologies Inc, Qiagen NV, Roche Holding AG ADR, Standard BioTools Inc, Stilla, Microsynth |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to polymerase chain reaction market will help companies and investors design strategic landscapes.
Conventional pcr was the largest segment with a revenue share of 9.87% in 2023. Horizon Databook has segmented the South Africa polymerase chain reaction market based on conventional pcr covering the revenue growth of each sub-segment from 2018 to 2030.
South Africa has a high burden of infectious diseases, such as HIV/AIDS and tuberculosis. The country has a large population prone to these diseases and requires focused detection tests & treatment. Increasing mortality rates and healthcare expenditures by government & private entities are expected to drive the market.
An increase in mortality and morbidity rates is anticipated to lead to an increased prevalence of diseases, resulting in the high use of PCR products. For instance, the South African government collaborated with UNO to improve healthcare measures to decrease mortality and increase life expectancy.
The rise in the prevalence of cancer in South Africa has led to an increase in the need for advanced genomics techniques to detect cancer. According to Lancet, a medical journal, South Africa will witness a 78% increase in cancer cases by 2030.
Horizon Databook provides a detailed overview of country-level data and insights on the South Africa polymerase chain reaction market , including forecasts for subscribers. This country databook contains high-level insights into South Africa polymerase chain reaction market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account